YU48484B - Kristalne kiselinske adicione soli diastereomerno čistih 1-(2,2-dimetilpropioniloksi)-etilestara 3-cefem-4-karbonske kiseline - Google Patents

Kristalne kiselinske adicione soli diastereomerno čistih 1-(2,2-dimetilpropioniloksi)-etilestara 3-cefem-4-karbonske kiseline

Info

Publication number
YU48484B
YU48484B YU33592A YU33592A YU48484B YU 48484 B YU48484 B YU 48484B YU 33592 A YU33592 A YU 33592A YU 33592 A YU33592 A YU 33592A YU 48484 B YU48484 B YU 48484B
Authority
YU
Yugoslavia
Prior art keywords
addition salts
pephem
dimethylpropyonyloxy
diastereometric
ethylesters
Prior art date
Application number
YU33592A
Other languages
English (en)
Other versions
YU33592A (sh
Inventor
Defossa Dr. Elisabeth
Fischer dr. Gerd
Jendralla Dr. Joachim-Heiner
Lattrell dr. Rudolf
Wollmann Dr. Theodor
Isert dr. Dieter
Original Assignee
Hoechst Aktiengesellschaft
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoechst Aktiengesellschaft filed Critical Hoechst Aktiengesellschaft
Priority to HRP-335/92 priority Critical patent/HRP940842B1/xx
Publication of YU33592A publication Critical patent/YU33592A/sh
Publication of YU48484B publication Critical patent/YU48484B/sh

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D501/00—Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • C07D501/14—Compounds having a nitrogen atom directly attached in position 7
    • C07D501/16—Compounds having a nitrogen atom directly attached in position 7 with a double bond between positions 2 and 3
    • C07D501/20—7-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids
    • C07D501/24—7-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids with hydrocarbon radicals, substituted by hetero atoms or hetero rings, attached in position 3
    • C07D501/26—Methylene radicals, substituted by oxygen atoms; Lactones thereof with the 2-carboxyl group
    • C07D501/34—Methylene radicals, substituted by oxygen atoms; Lactones thereof with the 2-carboxyl group with the 7-amino radical acylated by carboxylic acids containing hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D501/00—Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Communicable Diseases (AREA)
  • Animal Behavior & Ethology (AREA)
  • Oncology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Cephalosporin Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Steroid Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

Kristalne kiselinske adicione soli oba diastereomera 1-(2,2-dimetilpropioniloksi)-etilestra 3-cefem-4-karbonske kiseline, opšte formule II u kojoj X predstavlja anjon fiziološki neosporive, jednobazne ili višebazne, neorganske ili organske kiseline i grupa =N-OH stoji u sin položaju. - Prijava sadrži još 2 zavisna i 2 nezavisna zahteva.
YU33592A 1991-05-24 1992-03-30 Kristalne kiselinske adicione soli diastereomerno čistih 1-(2,2-dimetilpropioniloksi)-etilestara 3-cefem-4-karbonske kiseline YU48484B (sh)

Priority Applications (1)

Application Number Priority Date Filing Date Title
HRP-335/92 HRP940842B1 (en) 1991-05-24 1994-10-26 Crystalline acid addition salts of both diasttereomers of the 1-(2,2-dimethylpropionyloxy)-ethylester of 3-cephem-4-carboxylic acid

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE4116937 1991-05-24

Publications (2)

Publication Number Publication Date
YU33592A YU33592A (sh) 1995-03-27
YU48484B true YU48484B (sh) 1998-09-18

Family

ID=6432313

Family Applications (1)

Application Number Title Priority Date Filing Date
YU33592A YU48484B (sh) 1991-05-24 1992-03-30 Kristalne kiselinske adicione soli diastereomerno čistih 1-(2,2-dimetilpropioniloksi)-etilestara 3-cefem-4-karbonske kiseline

Country Status (29)

Country Link
US (2) US5594133A (sh)
EP (1) EP0514791B1 (sh)
JP (1) JPH0680065B2 (sh)
KR (1) KR100198908B1 (sh)
CN (1) CN1037608C (sh)
AT (1) ATE164377T1 (sh)
AU (1) AU652635B2 (sh)
BR (1) BR9201939A (sh)
CA (1) CA2069200C (sh)
CZ (1) CZ282299B6 (sh)
DE (1) DE59209246D1 (sh)
DK (1) DK0514791T3 (sh)
EG (1) EG20121A (sh)
ES (1) ES2115625T3 (sh)
FI (1) FI108435B (sh)
GR (1) GR3026625T3 (sh)
HR (1) HRP940842B1 (sh)
HU (1) HU220065B (sh)
IE (1) IE921660A1 (sh)
IL (1) IL101970A (sh)
MA (1) MA22532A1 (sh)
MX (1) MX9202460A (sh)
NO (1) NO301982B1 (sh)
PH (1) PH31070A (sh)
PL (3) PL170798B1 (sh)
RU (1) RU2073680C1 (sh)
SK (1) SK280291B6 (sh)
UY (1) UY23418A1 (sh)
YU (1) YU48484B (sh)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW212181B (sh) * 1992-02-14 1993-09-01 Hoechst Ag
ES2117066T3 (es) * 1992-05-21 1998-08-01 Hoechst Ag Procedimiento para la disociacion de esteres profarmacos de cefalosporina para dar acido 7-amino-3-metoximetil-cef-3-em-4-carboxilico.
AT401651B (de) * 1994-06-14 1996-11-25 Biochemie Gmbh 7-(2-(2-aminothiazol-4-yl)-2-(z)- hydroximinoacetamido)-3-n,n- dimethylcarbamoyloxymethyl-3-cephem-4-
AT408226B (de) * 1999-05-05 2001-09-25 Biochemie Gmbh Kristalliner 7-(2-(2-formylaminothiazol-4-yl)-2
WO2004056834A1 (en) * 2002-12-20 2004-07-08 Lupin Limited A process for the preparation of cefpodoxime proxetil
EP1583764A1 (en) * 2003-01-06 2005-10-12 Lupin Limited A process for the manufacture of cefpodoxime proxetil

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK154939C (da) * 1974-12-19 1989-06-12 Takeda Chemical Industries Ltd Analogifremgangsmaade til fremstilling af thiazolylacetamido-cephemforbindelser eller farmaceutisk acceptable salte eller estere deraf
JPS5760345B2 (sh) * 1974-12-19 1982-12-18 Takeda Chemical Industries Ltd
US4298606A (en) * 1974-12-19 1981-11-03 Takeda Chemical Industries, Ltd. Thiazolylacetamido compounds
US4668783A (en) * 1974-12-19 1987-05-26 Takeda Chemical Industries, Ltd. Thiazolylacetamido cephalosporin compounds
US4203899A (en) * 1974-12-19 1980-05-20 Takeda Chemical Industries, Ltd. Thiazolylacetamido compounds
DE2760123C2 (de) * 1976-01-23 1986-04-30 Roussel-Uclaf, Paris 7-Aminothiazolyl-syn-oxyiminoacetamidocephalosporansäuren, ihre Herstellung und sie enthaltende pharmazeutische Zusammensetzungen
JPS6011713B2 (ja) * 1976-09-08 1985-03-27 武田薬品工業株式会社 セフアロスポリン誘導体およびその製造法
DE2714880A1 (de) * 1977-04-02 1978-10-26 Hoechst Ag Cephemderivate und verfahren zu ihrer herstellung
US4409215A (en) * 1979-11-19 1983-10-11 Fujisawa Pharmaceutical Co., Ltd. 7-Acylamino-3-substituted cephalosporanic acid derivatives and processes for the preparation thereof
FR2476087A1 (fr) * 1980-02-18 1981-08-21 Roussel Uclaf Nouvelles oximes derivees de l'acide 3-alkyloxy ou 3-alkyl-thiomethyl 7-amino thiazolyl acetamido cephalosporanique, leur procede de preparation et leur application comme medicaments
JPS5759894A (en) * 1980-09-30 1982-04-10 Sankyo Co Ltd Cephalosporin for oral administration
US4486425A (en) * 1980-09-30 1984-12-04 Sankyo Company Limited 7-[2-(2-Aminothiazol-4-yl)-2-(syn)-methoxyiminoacetamido]-3-methoxymethyl-3-cephem-4-carboxylates
DE3804841A1 (de) * 1988-02-17 1989-08-31 Hoechst Ag Cephalosporinderivate und verfahren zu ihrer herstellung
DE3919259A1 (de) * 1989-06-13 1990-12-20 Hoechst Ag Kristalline cephem-saeureadditionssalze und verfahren zu ihrer herstellung

Also Published As

Publication number Publication date
KR920021558A (ko) 1992-12-18
PL294651A1 (en) 1993-01-25
EP0514791B1 (de) 1998-03-25
HU220065B (hu) 2001-10-28
CN1037608C (zh) 1998-03-04
FI922310A0 (fi) 1992-05-21
PL170403B1 (pl) 1996-12-31
IL101970A0 (en) 1992-12-30
KR100198908B1 (ko) 1999-06-15
GR3026625T3 (en) 1998-07-31
EG20121A (en) 1997-07-31
IE921660A1 (en) 1992-12-02
NO301982B1 (no) 1998-01-05
HRP940842A2 (en) 1997-02-28
CA2069200C (en) 2004-01-27
US5556850A (en) 1996-09-17
FI922310A (fi) 1992-11-25
JPH05178861A (ja) 1993-07-20
ES2115625T3 (es) 1998-07-01
PL170962B1 (pl) 1997-02-28
UY23418A1 (es) 1992-06-05
NO922023D0 (no) 1992-05-22
NO922023L (no) 1992-11-25
YU33592A (sh) 1995-03-27
CZ154792A3 (en) 1993-08-11
HUT61768A (en) 1993-03-01
EP0514791A2 (de) 1992-11-25
US5594133A (en) 1997-01-14
SK154792A3 (en) 1995-08-09
CZ282299B6 (cs) 1997-06-11
DE59209246D1 (de) 1998-04-30
IL101970A (en) 1996-05-14
PH31070A (en) 1998-02-05
HU9201716D0 (en) 1992-08-28
CA2069200A1 (en) 1992-11-25
AU652635B2 (en) 1994-09-01
MA22532A1 (fr) 1992-12-31
FI108435B (fi) 2002-01-31
JPH0680065B2 (ja) 1994-10-12
MX9202460A (es) 1992-11-01
CN1067055A (zh) 1992-12-16
RU2073680C1 (ru) 1997-02-20
HRP940842B1 (en) 2001-02-28
ATE164377T1 (de) 1998-04-15
BR9201939A (pt) 1993-01-12
DK0514791T3 (da) 1998-12-21
SK280291B6 (sk) 1999-11-08
PL170798B1 (pl) 1997-01-31
EP0514791A3 (en) 1993-03-03
AU1706292A (en) 1993-03-11

Similar Documents

Publication Publication Date Title
ES8705387A1 (es) Un procedimiento para preparar derivados de n-aril-n-(4-piperidinil)-alcoxialquilamida
NO900855L (no) Substituerte pyrroler.
CA2033392A1 (en) A-nor-steroid-3-carboxylic acid derivatives
ES2159798T3 (es) Derivados heterociclicos como inhibidores de la agregacion plaquetaria.
EP0370481A3 (de) Pharmazeutische Präparate zur verbesserten Resorption antibakterieller Verbindungen
EP0366641A3 (en) Novel antimicrobial quinolonyl lactam esters
YU48484B (sh) Kristalne kiselinske adicione soli diastereomerno čistih 1-(2,2-dimetilpropioniloksi)-etilestara 3-cefem-4-karbonske kiseline
GB2259702B (en) Polybasic acid esters as oil field corrosion inhibitors
DK0499926T3 (sh)
MX9301361A (es) Derivados de carbapenema antimicrobianos y su preparacion.
FI863724A (fi) Nya dispergerbara, aktiva limkompositioner.
YU46914B (sh) Metoksimetilna jedinjenja
FR2687667B1 (fr) Esters d'acides carboxyliques d'hydroxyphenylalcanols comme stabilisants.
CA2173505A1 (en) Use of penciclovir for the treatment of post-herpetic neuralgia
IE800960L (en) Phenylthioethyl carboxylic acid hydrazides
GR3036631T3 (en) Preparation and utilisation of pure enantiomers of 8-halogen-6-hydroxyoctanoic acid, their alkyl esters and their salts with pure enantiomers of alpha-methyl-benzylamines
YU47871B (sh) Derivati aminokiselina
SE9601483D0 (sv) Beredning av komposition
ITFI910180A0 (it) Sistema di defribillazione cardiaca per limitare l'energia erogata al paziente
CA2193128A1 (en) Fungicidal mixtures